FBC Device ApS Receives First US Patent for Interbody Fusion Device Allowing Patient Determined Alignment of Spine

AARHUS, Denmark–(BUSINESS WIRE)–FBC Device ApS, a medical device company developing the Statur® line of spinal interbody fusion implants, has received its first US patent covering a series of two piece implants that enable natural spinal alignment. The Patent number US 8,007,536 is titled “Disc Implant.”

“This novel concept holds the promise of improved outcomes, while taking advantage of well-accepted surgical techniques.”

Professor Finn Christensen, MD, PhD, founder and CEO of FBC Device says:

“When treating fusion patients, I realized many years ago that alignment was critical to a successful surgery. Unfortunately, alignment of the bones in the operative theatre is not the same alignment obtained when the patient is up and walking. So we invented a two piece interbody fusion device that allows for temporary relative movement between the two components so that the patient’s body by itself can determine the appropriate position for fusion; what we call natural balance™.” Dr. Christensen adds, “This novel concept holds the promise of improved outcomes, while taking advantage of well-accepted surgical techniques.”

For more information, visit www.fbcdevice.com

About FBC Device ApS

FBC Device ApS, headquartered in Aarhus, Denmark, is developing new implant concepts and designs with the aim to improve treatment of patients with degenerated spinal disorders by optimizing functional outcome and quality of life on long-term basis.

About the Statur® Line of Interbody Implants

The Statur® line of interbody fusion implants is designed to enable natural balance of the fused spine for patients. Statur® is expected to offer the advantage of better results for patients receiving the implant, while holding out the potential to reduce the incidence of adjacent segment disc disease.